Wednesday, January 11, 2012
ImmunoCellular Therapeutics Ltd., of Woodland Hills, Calif., priced an underwritten offering of 9.49 units at $1.10 per unit for net proceeds of about $9.4 million. The units consist of one share of common stock and a warrant to buy one half share of common stock. The warrants have a five-year term and are exercisable at $1.41 per share.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.